about
The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data.Carbonic Anhydrase Activity Monitored In Vivo by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in Tumors.Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinationsEvaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance ImagingA comparison of quantitative methods for clinical imaging with hyperpolarized (13)C-pyruvateDynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease.A method for mapping and quantifying whole organ diffusion-weighted image distortion in MR imaging of the prostate.An investigation into the effects of temporal resolution on hepatic dynamic contrast-enhanced MRI in volunteers and in patients with hepatocellular carcinoma.The longitudinal effect of ejaculation on seminal vesicle fluid volume and whole-prostate ADC as measured on prostate MRI.A functional form for injected MRI Gd-chelate contrast agent concentration incorporating recirculation, extravasation and excretion.A semi-automatic method for the extraction of the portal venous input function in quantitative dynamic contrast-enhanced CT of the liver.The Effect of Different Drinking and Voiding Preparations on Magnetic Resonance Imaging Bladder Distention in Normal Volunteers and PatientsDCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: A feasibility studyQuantifying normal human brain metabolism using hyperpolarized [1-C]pyruvate and magnetic resonance imagingSodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancerRole of PROPELLER-DWI of the prostate in reducing distortion and artefact from total hip replacement metalworkDiffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancerctDNA monitoring using patient-specific sequencing and integration of variant reads
P50
Q30873526-B9727A70-A935-4EB2-9A1A-8C15DF140D95Q30985593-8FFD073E-A10A-4A0C-BF14-DD6DF84BC87AQ33841446-5EDFF379-D02E-43CF-A8DA-AD16F7C4A8E0Q36088325-B2012501-66CD-41E0-A0D8-1DAC301F4129Q36802166-B877962C-DA2B-491E-9CB6-9F1C63E06340Q39885166-4A3550A6-DB35-427F-BF45-6B55CDCC1798Q42149311-824588A8-AC7F-435A-9CB0-D858BA3FBA00Q44548089-DF64C6C0-30DE-46DA-9D40-3122257ACACBQ46896123-BA594DA4-F4DD-4DD5-9396-FBC7A60C560CQ47590197-3B1A3E15-03B2-491F-8F4B-3E693953B32FQ47842632-FCAF06B8-B191-49E7-BD7B-82CC285903E3Q57475073-05C9AAD4-F937-4D48-9809-52A6CFCC74AEQ63965996-E1543C32-6027-4520-B6EB-3DA4D59DF041Q64096467-539502AB-03B8-48DB-94FF-060E57FF7708Q64100548-0A6038C2-5E86-4C22-970C-27602A125D65Q88445294-893167CC-ED32-479A-A8D3-4E28C5EECEE6Q92153808-E85916B4-8B43-4C8C-B1F0-BDA5887DC182Q96591156-611D83EB-3689-4260-8722-7E715368FB84
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrew B Gill
@ast
Andrew B Gill
@en
Andrew B Gill
@es
Andrew B Gill
@nl
type
label
Andrew B Gill
@ast
Andrew B Gill
@en
Andrew B Gill
@es
Andrew B Gill
@nl
prefLabel
Andrew B Gill
@ast
Andrew B Gill
@en
Andrew B Gill
@es
Andrew B Gill
@nl
P106
P31
P496
0000-0002-9287-9563